Travere Therapeutics Inc (NASDAQ:TVTX)
| 21.66 Delayed Data As of Mar 28 |  +0.02 / +0.09%Today’s Change | 17.82 Today|||52-Week Range 30.35 | +3.00% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 99.9M | 133.6M | 154.9M | 164.2M | |
| Cost of Goods Sold | 2.0M | 4.6M | 3.6M | 4.9M | ||
| Depreciation And Amortization | 13.4M | 16.1M | 17.8M | 18.7M | ||
| Operating Expenses | Gross Income | 84.5M | 112.9M | 133.5M | 140.7M | |
| General Expenses | 116.7M | 147.5M | 161.7M | 209.4M | ||
| Research And Development | 49.7M | 70.5M | 77.8M | 122.8M | ||
| Total Operating Expenses | 132.2M | 168.2M | 183.1M | 232.9M | ||
| Non-Operating Expenses | Operating Income | -32.3M | -34.6M | -28.2M | -68.7M | |
| Extraordinary Credit | 15.5M | 1.7M | 0.00 | 242.0K | ||
| Extraordinary Charge | -55.9M | -23.6M | -30.1M | -28.6M | ||
| Interest Expense On Debt | 10.6M | 2.7M | 1.9M | 9.8M | ||
| Other Expenses | 188.8M | -264.0K | 1.1M | -474.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 105.5M | -57.6M | -58.4M | -101.9M | |
| Income Taxes | -11.8M | -9.7M | -1.4M | -811.0K | ||
| Net Income | 117.2M | -47.9M | -59.7M | -102.7M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 33.6M | 37.0M | 38.8M | 40.4M | |
| Shares To Calculate EPS Diluted | 37.6M | 38.3M | 38.8M | 40.4M | ||
| Earnings Per Share | EPS | $3.17 | -$1.29 | -$1.54 | -$2.54 | |
| EPS Diluted | $3.17 | -$1.29 | -$1.54 | -$2.54 | ||
